Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Gwenoline Borhis
Introduction
Gwenoline Borhis is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of immunology through his innovative inventions. With a total of 2 patents, Borhis has focused on developing therapeutic antibodies that have the potential to enhance immune responses in patients.
Latest Patents
Among his latest patents are the "Antagonists anti-CD7 antibodies" and "Anti-ICOS antibodies." The first invention relates to Cluster of Differentiation 7 (CD7) antagonists, including antibodies and fragments, along with methods, uses, and combinations. The second patent involves antibodies that bind to ICOS (Inducible T cell Co-Stimulator). This invention aims to modulate the ratio between regulatory T cells and effector T cells, thereby stimulating the immune system of patients, particularly in the context of cancer treatment. Additionally, it includes methods for producing anti-ICOS antibodies, including species cross-reactive antibodies, utilizing transgenic knock-out mice.
Career Highlights
Gwenoline Borhis is currently associated with Kymab Limited, where he continues to advance his research and development efforts. His work has been instrumental in pushing the boundaries of therapeutic applications in immunology.
Collaborations
Gwenoline has collaborated with notable colleagues, including E-Chiang Lee and Miha Kosmac, to further enhance the impact of his research and inventions.
Conclusion
Gwenoline Borhis stands out as an influential inventor in the field of immunology, with his innovative patents paving the way for new therapeutic approaches. His contributions are expected to have a lasting impact on the treatment of various diseases, particularly cancers.